STEVEN C GILMAN Insider Trading $AKBA Akebia Therapeutics, Inc.
Get free email notifications about insider trading for STEVEN C GILMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN C GILMAN. STEVEN C GILMAN is EVP & Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and Senior Vice President in CUBIST PHARMACEUTICALS INC ($CBST) and SVP, Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in SCYNEXIS INC ($SCYX) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and CEO in CONTRAFECT Corp ($CFRX) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
STEVEN C GILMAN in Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN:
Holdings: 43,431 shares
Current Value: $429,098
Latest Transaction: Jun 09 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEVEN C GILMAN in Akebia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, CFRX, CBST, KERX, MNTA, SCYX, ASTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Sell | S | 12.08 | 4,567 | 55,169 | 38,864 | 43.4 K to 38.9 K (-10.52 %) | |
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Grant | A | 0.00 | 13,700 | 0 | 43,431 | 29.7 K to 43.4 K (+46.08 %) | |
| Nov 22 2019 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Buy | P | 3.43 | 5,800 | 19,894 | 29,731 | 23.9 K to 29.7 K (+24.24 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Grant | A | 0.00 | 13,700 | 0 | 23,931 | 10.2 K to 23.9 K (+133.91 %) | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 15.26 | 11,229 | 171,355 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Option Exercise | A | 12.48 | 18,716 | 233,576 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | GILMAN STEVEN C | Director | Grant | A | 0.00 | 10,231 | 0 | 10,231 | 0 to 10.2 K |
Page: 1